ウィルムス腫瘍による死亡率の低下

Same author

Definitive radiotherapy for T1 and T2 squamous cell carcinoma of the tonsil.

Head & neck·1995

Same author

Craniofacial resection at the University of Virginia (1976-1992): survival analysis.

Head & neck·1994

Same author

Esthesioneuroblastoma. Long-term outcome and patterns of failure--the University of Virginia experience.

Cancer·1994

Same author

Glomus jugulare tumors. Long-term control by radiation therapy.

Cancer·1992

Same author

Phase I/II trial of superselective arterial 5-FU infusion with concomitant external beam radiation for patients with either anaplastic astrocytoma or glioblastoma multiforme.

American journal of clinical oncology·1991

Same author

The influence of extent of neck treatment upon control of cervical lymphadenopathy in cancers of the oral tongue.

International journal of radiation oncology, biology, physics·1991

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

関連する実験動画

ウィルムス腫瘍による死亡率の低下

関連する概念動画

Definitive radiotherapy for T1 and T2 squamous cell carcinoma of the tonsil.

Craniofacial resection at the University of Virginia (1976-1992): survival analysis.

Esthesioneuroblastoma. Long-term outcome and patterns of failure--the University of Virginia experience.

Glomus jugulare tumors. Long-term control by radiation therapy.

Phase I/II trial of superselective arterial 5-FU infusion with concomitant external beam radiation for patients with either anaplastic astrocytoma or glioblastoma multiforme.

The influence of extent of neck treatment upon control of cervical lymphadenopathy in cancers of the oral tongue.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

関連する実験動画

ウィルムス腫瘍による死亡率の低下

関連する概念動画

関連記事

Definitive radiotherapy for T1 and T2 squamous cell carcinoma of the tonsil.

Craniofacial resection at the University of Virginia (1976-1992): survival analysis.

Esthesioneuroblastoma. Long-term outcome and patterns of failure--the University of Virginia experience.

Glomus jugulare tumors. Long-term control by radiation therapy.

Phase I/II trial of superselective arterial 5-FU infusion with concomitant external beam radiation for patients with either anaplastic astrocytoma or glioblastoma multiforme.

The influence of extent of neck treatment upon control of cervical lymphadenopathy in cancers of the oral tongue.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.